Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROMISE study in MINOCA
2020-006009-43Phase 4Active
- Sponsor
- Policlinico Gemelli
- Start
- Jun 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of acetylcholine, diltiazem, clopidogrel, warfarin, nitroglycerin and 4 more in myocardial infarction with nonobstructive coronary arteries (MINOCA), sponsored by Policlinico Gemelli. Started Jun 2021; status: active.
02
Drugs
acetylcholinediltiazemclopidogrelwarfarinnitroglycerin
03
Conditions
myocardial infarction with nonobstructive coronary arteries (MINOCA)
Beyond the preview
Go deeper on 2020-006009-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-006009-43.